|  Help  |  About  |  Contact Us

Publication : Niclosamide activates the NLRP3 inflammasome by intracellular acidification and mitochondrial inhibition.

First Author  Thi Tran U Year  2019
Journal  Commun Biol Volume  2
Pages  2 PubMed ID  30740538
Mgi Jnum  J:288624 Mgi Id  MGI:6433650
Doi  10.1038/s42003-018-0244-y Citation  Thi Tran U, et al. (2019) Niclosamide activates the NLRP3 inflammasome by intracellular acidification and mitochondrial inhibition. Commun Biol 2:2
abstractText  The NLRP3 inflammasome is unique among pattern recognition receptors in using changes in cellular physiology as a mechanism for sensing host danger. To dissect the physiological network controlling inflammasome activation, we screened for small-molecule activators and suppressors of IL-1beta release in macrophages. Here we identified niclosamide, a mitochondrial uncoupler, as an activator of NLRP3 inflammasome. We find that niclosamide inhibits mitochondria and induces intracellular acidification, both of which are necessary for inflammasome activation. Intracellular acidification, by inhibiting glycolysis, works together with mitochondrial inhibition to induce intracellular ATP loss, which compromises intracellular potassium maintenance, a key event to NLRP3 inflammasome activation. A modest decline in intracellular ATP or pH within an optimal range induces maximum IL-1beta release while their excessive decline suppresses IL-1beta release. Our work illustrates how energy metabolism converges upon intracellular potassium to activate NLRP3 inflammasome and highlights a biphasic relationship between cellular physiology and IL-1beta release.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Authors

0 Bio Entities

0 Expression